switched from semaglutide to tirzepatide Switching Tirzepatide: A Provider's Guide Switching from Semaglutide to Tirzepatide:

Patients who stopped abruptly regained much faster

If 12 to 16 weeks at the maintenance dose produces less than 5% weight loss, guidelines support discontinuing and reassessing the treatment plan

Sometimes a small bubble of air gets trapped in the main part of the syringe

Both semaglutide and liraglutide were shown to significantly increase weight loss in this patient population due to slower gastric emptying time, increased satiety, decreased hunger and food cravings, as well as alteration of the food reward pathway

NICE recommends considering bariatric surgery for adults with a BMI of 40 kg/m or more, or 35 to 40 kg/m with significant comorbidities